Fertility Preservation and Sexual Health After Cancer Therapy

J Oncol Pract. 2017 Oct;13(10):643-651. doi: 10.1200/JOP.2017.023705. Epub 2017 Aug 15.

Abstract

Recent developments in cancer diagnostics and treatments have considerably improved long-term survival rates. Despite improvements in chemotherapy regimens, more focused radiotherapy and diverse surgical options, cancer treatments often have gonadotoxic side-effects that can manifest as loss of fertility or sexual dysfunction, particularly in young cancer survivors. In this review, we focus on two pertinent quality-of-life issues in female cancer survivors of reproductive age-fertility preservation and sexual function. Fertility preservation encompasses all clinical and laboratory efforts to preserve a woman's chance to achieve future genetic motherhood. These efforts range from well-established protocols such as ovarian stimulation with cryopreservation of embryos or oocytes, to nascent clinical trials involving cryopreservation and re-implantation of ovarian tissue. Therefore, fertility preservation strategies are individualized to the cancer diagnosis, time interval until initiation of treatments must begin, prognosis, pubertal status, and maturity level of patient. Some patients choose not to pursue fertility preservation, and the conversation then centers around other quality of life issues. Not all cancer treatments cause loss of fertility; however, most treatments can directly impact the physical and psychosocial aspects of sexual function. Cancer treatment is also associated with fear, anxiety, and depression, which can further decrease sexual desire, function, and frequency. Sexual dysfunction after cancer treatment is generally ascertained by compassionate inquiry. Strategies to promote sexual function after cancer treatment include pelvic floor exercises, clitoral therapy devices, pharmacologic agents, as well as couples-based psychotherapeutic and psycho-educational interventions. Quality-of-life issues in young cancer survivors are often best addressed by utilizing a multidisciplinary team consisting of physicians, nurses, social workers, psychiatrists, sex educators, counselors, or therapists.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Cryopreservation
  • Female
  • Fertility Preservation / methods*
  • Humans
  • Infertility, Female / etiology
  • Infertility, Female / prevention & control*
  • Neoplasms / therapy*
  • Oocyte Retrieval
  • Ovariectomy
  • Ovulation Induction
  • Quality of Life
  • Radiotherapy / adverse effects
  • Replantation
  • Sexual Dysfunction, Physiological / etiology
  • Sexual Dysfunction, Physiological / therapy*
  • Sexual Dysfunctions, Psychological / etiology
  • Sexual Dysfunctions, Psychological / therapy*
  • Sexual Health*
  • Surgical Procedures, Operative / adverse effects

Substances

  • Antineoplastic Agents